Coagulation factor V (F5) iRNA compositions and methods of use thereof
US12331297B2 · kind B2 · utility
0Cited by
7References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 26, 2024 |
| Grant date | Jun 17, 2025 |
| Priority date | — |
| Expiry date | Feb 26, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/346
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to RNAi agents, e.g., dsRNA agents, targeting the Coagulation Factor V (F5) gene. The invention also relates to methods of using such RNAi agents to inhibit expression of an F5 gene and to methods of treating or preventing an F5-associated disease, e.g., a disorder associated with thrombosis, in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.